| Particulars |
| Company Name |
Glaxosmithkline Pharmaceuticals Ltd |
| Face Value |
10 |
| BSE Code |
500660 |
| Year End |
202603 |
| Full Year |
| Equity (Rs in Cr.) |
169.41 |
| B.V. Rs |
132.30 |
| Sales Rs in Cr. |
3,790.20 |
| NP Rs in Cr. |
907.82 |
| NP Var% |
10.00 |
| Div% |
570.00 |
| CPS Rs |
57.50 |
| EPS Rs |
53.60 |
| Traded Value(Rs in Lakhs) |
7,403.76 |
| 52 Week High |
3,500.00 |
| 52 Week Low |
2,088.00 |
| Price BSE |
2,121.00 |
| Price NSE |
2,122.00 |
| Market Capital(Rs in Cr.) |
35,925.94 |
| P/C Ratio |
36.90 |
| P/E Ratio |
39.60 |
| Price Vs.BV |
16.03 |
| Latest Quarter |
| Year End |
202603 |
| Sales Rs in Cr. |
989.15 |
| NP Rs in Cr. |
274.94 |
| NP Var % |
6.00 |
| Trailing Twelve Months |
| Year End |
202603 |
| Sales |
3,526.90 |
| OPM |
-6.11 |
| NP |
795.84 |
| NP Var% |
9.77 |
| EPS |
53.59 |
| PE |
39.57 |
|